Reduced risk of heart disease by 20%! Novo Nordisk A/S's (NVO.US) weight loss drug, Wegovy, has won a new indication in the European Union.
The European Medicines Agency (EMA) supports the use of Wegovy to reduce the risk of major cardiovascular disease and stroke in overweight or obese adults.
EC Conditionally Approves Pfizer's Haemophilia B Gene Therapy
How To Earn $100 Per Month From Pfizer Stock
Pfizer Options Spot-On: On July 25th, 837.97K Contracts Were Traded, With 2.78 Million Open Interest
Pandion Optimization Alliance Celebrates Excellence at 2nd Annual GOAT Awards
Express News | CNBC Halftime Report Final Trades: Freeport-McMoRan, Pfizer, Danaher, United Rentals
What's Going On With Pfizer Stock Thursday?
Pfizer Hemophilia B Gene Therapy Durveqtix Wins EC Authorization
Pfizer Gets EC's Conditional Authorization For Durveqtix Genetherapy In Hemophilia B
Pfizer's Hemophilia B Treatment Gets Conditional Marketing Authorization in Europe
Pfizer Gets European Commission Marketing Approval for Durveqtix
Express News | European Commission Approves Pfizer’s Durveqtix® (Fidanacogene Elaparvovec), a One-Time Gene Therapy for Adults With Hemophilia B
Pfizer's Options: A Look at What the Big Money Is Thinking
Pfizer Hits 37-week High
Seeking Clues to Pfizer (PFE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
The “up-and-coming diet drug” Viking (VKTX.US) drug enters the late stages of development, and the “Nolie” stock price fell in shock
As the Viking diet pill entered the later stages of clinical trials, Eli Lilly and Novo Nordisk stock prices declined.
Viking Sends Lilly, Novo Lower as Obesity Drug Enters Late-stage Program
Analyzing BioMarin's Position Amid Pfizer's Emergent Gene Therapy and Projected Market Impact
Pfizer (PFE) Gains 7.3% in 2024 on Its Weigh-Loss Drug Pipeline